Researchers at the BioMed X Institute and the Universitätsmedizin Mannheim just published the results of their collaboration around a new neoepitope vaccine in diffuse midline glioma in Science Advances.
Read MoreAfter successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore tumor immunogenicity enhancers.
Read MoreGordon Levinson, founder of the Levinson Law Group, arranged for a charitable grant to be given in support of childhood cancer research.
Read MoreThree-dimensional microscale hanging drop arrays are useful in drug discovery, regenerative medicine, stem cell research, and biotechnology.
Read MoreLive Like Bella® founded in 2013 has approved a grant to Aurora Biopharma to admit children for the first time into their cutting-edge Immunotherapy research. This is incredible news for the Cancer Community and especially children suffering with the very deadly forms of cancer known as Glioblastoma (Brain Cancer) and Osteocracoma (Bone Cancer) .
Read MoreCOTI-2 demonstrates selective and potent anti-cancer p53-dependent activity in definitive experiments. Critical Outcome and MD Anderson Cancer Center sign letter of intent for phase 1 development of COTI-2.
Read MoreStar Health Network, Inc. (Star) and Rajiv Gandhi Cancer Institute & Research Center (RGCI&RC) are proud to announce the availability of molecular Tumor Profiling (TP) tests from the Yale School of Medicine and Thomas Jefferson University, USA.
Read MoreA new collaboration between the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) and Highlands Oncology Group will advance research in Arkansas and give greater access to care.
Read MoreHighlands Oncology Group (HOG) has been involved in a breakthrough trial studying the effects of a combination of two medications on the treatment of refractory metastatic pancreatic cancer.
Read MoreMedical Oncologist, Dr. Nicholas Vogelzang recently presented data on the drug Xofigo at the annual meeting of the American Society of Clinical Oncology.
Read MoreCancer Research UK funds over half of the UK's cancer research. CR UK turned to Sigmer Technologies to develop and manage a large research survey targeting clinicians in 10 jurisdictions throughout the World.
Read MoreThe HERA Women's Cancer Foundation, a nationally recognized ovarian cancer nonprofit, is accepting registrations for the 11th Annual Climb4Life Utah. Fundraising series aims to raise $100k to help fight ovarian cancer.
Read More